Seven companies are supplying flu vaccines this year

Excluding SK Bioscience, Dong-A ST, and LG Chem

SK Bioscience will focus on COVID vaccine after consulting with the KDCA.

 

The market share of the GC Pharma is likely to increase.

 

Two imported vaccines including Sanofi and GSK Flu vaccines, which will be distributed and sold in Korea this year, are nine items from seven companies, down three from the previous year.

 

SK Bioscience, which had the highest sales performance of flu vaccines last year, will not supply them this year due to the production of COVID-19 vaccine, and Dong-A ST and LG Chem have also been excluded from the market.

 

According to the MFDS on the 17th, domestic manufacturers that distribute flu vaccines this year are Boryung Bio (2 items), Boryung, GC Pharma (2 items), Il Yang (2 items), and the importers are Sanofi Pasteur and GlaxoSmithKline.

 

Compared to last year, SK Bioscience, Dong-A ST, and LG Chem were excluded.

 

SK Bioscience has been unable to distribute flu vaccines in Korea this year due to the production of COVID vaccine.

 

SK Bioscience is commissioning and producing AZ and Novavax vaccine and is also developing its own products.

 

A company official said, "The existing production line of the flu vaccine at Andong plant is producing COVID vaccines, in consultation with the KDCA, we decided not to supply flu vaccines this year." SK Bioscience recorded the highest performance in Korea last year, with production of only 4-valent flu vaccine worth ₩164.7 billion.

 

As SK Bioscience is out this year, only two companies that produce raw material to finished products in Korea will remain: GC Pharma and Il Yang.

 

The share of GC Pharma, which recorded the second highest production performance of ₩82.9 billion after SK Bioscience last year, is expected to increase significantly.

 

In the case of Dong-A ST, the company received the original amount from Sanofi and manufactured and supplied the finished product, but due to the expiration of the contract, Vaxiflu Tetra Injection Solution Prefilled Syringe was revoked in January.

 

LG Chem, which receives products from GC Pharma, is not selling flu vaccines this year.

 

Like last year, Sanofi Pasteur and Glaxosmithkline distribute imported vaccines.

 

However, Sanofi Pasteur participates in NIP for children and pregnant women under the age of 13.

 

It is explained that the mandatory vaccination for national procurement aged 65 or older was not available because it was difficult to meet the supply schedule suggested by the KDCA.

 

It is known that importers such as GSK do not actively participate due to the same low cost of the national mandatory vaccination project as last year.

 

The MFDS predicts that about 28.8 million flu vaccines will be distributed this year.

 

Among them, 14.6 million people were involved in the NIP project.

 

Last year, National lot releases for 29 million people were distributed.

 

As of the 13th, the national lot release for 3.66 million people was received.